Executive Overview

Thirty years of extraordinary accomplishments in driving business growth in the healthcare products and services industry. Twenty years in senior management and related cross functional positions in one of the worldís largest pharmaceutical companies. Significant global experience as an expatriate in Europe. Headed two successful start-up companies.

Areas of expertise include:

View SGS Executive ProfilePDF icon
View entire resume PDF icon
  • Board of Directors
  • General Management
  • Sales and Marketing Management
  • Business Development
  • Strategic Planning
  • Government Affairs




Chief Executive Officer, Philadelphia, Pennsylvania

Responsible for the overall Management and Development of the ZAR Medical operation. The vision of ZAR Medical is to become a leading provider of innovative products in a variety of areas within the healthcare space with the potential to substantially alter patient outcomes in disease states and conditions where there is a significant unmet need.

  • CEO and Member, Board of Directors



Montclair, NJ
Chairman and Chief Executive Officer

Responsible for the delivery of Consulting and Advisory Services to Senior Management and Boards of Directors in the health care and related industries. Client companies include Biotechnology and Pharmaceutical Companies.

Services Include:

  • Board of Directors
  • Short Term General Management (CEO/CFO/COO)
  • Investor and M&A Advisor
  • Small Company CEO Mentoring and GM Development



Pinebrook, NJ
President and Chief Executive Officer

Responsible for all aspects of the management and development of the EluSys worldwide operation.

  • Recruited a Board of Directors and Scientific Advisory Board that are composed of among the most notable leaders in science and business within the Biotechnology industry.
  • Located and leased office and laboratory space in Pine Brook, New Jersey, to satisfy the company’s need for a corporate headquarters.
  • Assembled a world-class operational management team consisting of proven executives with broad expertise and a blend of large Pharmaceutical industry and small entrepreneurial start-up corporate experience.
  • Contributed to the raising of $12 million in funds through a Series B offering, and led the Series C and D offerings, which resulted in the raising of approximately $30 million.
  • Secured funding from the federal government through research grants from NIH and DOD totaling in excess of $30 million.
  • Negotiated a line of credit for the purchase of laboratory and office equipment, furniture and necessary facility improvements and construction.
  • Managed the construction of a new state-of-the art facility for both laboratory and business operations.
  • Built an intellectual property portfolio to ensure the protection of the company's proprietary technologies and their broad application in the global marketplace.
  • Forged collaborations with a wide variety of companies, academic institutions and individuals to enable the company’s technology to develop toward commercialization expeditiously.
  • Established the necessary systems, processes and operating infrastructure to facilitate the smooth, continuous and efficient operation of the company.
  • Formulated a plan with the management team to develop and fully commercialize all aspects of the Elusys monoclonal antibody based technologies.
  • Led the company in implementation of the Elusys business plan.



Roche Laboratories Inc.
Division of Hoffmann-La Roche, Inc.

President, Roche Laboratories Inc.

Responsible for the ongoing commercial operations of the U.S. Pharmaceuticals business.  Member of the Pharmaceutical Leadership Board and Chairman of the Roche Business Operating Committee.  Responsible for U.S. related therapeutic area planning for drug discovery and portfolio management for drug development. 

  • More than tripled US revenues in 10 years.
  • Consistently increased divisional profit contribution.
  • Substantially increased Roche share of the US market.
  • Prepared the organization for the launch of many large products.
  • Developed a long-term plan to double the business in the next five years.
  • Reorganized Roche Labs entirely to better align the company with the rapidly changing health care marketplace.
  • Integrated the Boehringer Mannheim US operations into Roche Laboratories. Inc.
  • Recruited and developed a talent pool of high caliber senior managers for current and future needs of Roche.
  • Negotiated major co promotion agreement to fill a gap in revenues created by the removal of a substantial product from the market.
  • Served as member on Hoffmann La Roche Inc. Board of Directors and Executive Committee.


View entire resume PDF icon

back to top

jordan 3 wolf grey louis vuitton outlet sport blue 3s Lebron 11 sport blue 3s foamposites shooting stars louis vuitton outlet Louis Vuitton Outlet sport blue 3s louis vuitton outlet kate spade outlet michael kors outlet michael kors outlet kate spade outlet louis vuitton outlet michael kors outlet kate spade handbags Michael Kors Outlet Sport Blue 6s louis vuitton outlet